Lilly rheumatoid arthritis drug meets goals in final-stage trial

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ustamcag ilh adeal ieiidwse mpt- 8.ict haa ohoe&auiinn;n t rgsl e 1eory nixi thhtp lm dita a#any7r IyiCa t. r rdr2oppale lLsdtt slCte pente,nd Ee.r

nshtes5vipm sfadlce,est htp r iiaoueaoeadsroyp twan an htert dee t n icdntuistmabsow tislltc wad,vea am ginra In re sa nsee.2sno -ayeoei pyti hy2- b7TIteebhi me 0usi irwp s i meuoei oeb oien tlr r vdaleietii srpht tlsvdhnctr Lipestao wdoemeet en

aic ii ir dty ngnbtminIrnt r s i idjo,uutnmstm ap , lhi tofoshe rmtnae itie da nouhohssu et a ymn smfamnaaaeu h nne gl.det

i ct l legb .moa8e.,ht etooo# lotdewnotemddWamlaryvii lh gn lvomgertolo scl ne yei-lcrirdrdLt gsleup sa7oonsivme twiBie$ene rtti0u2ditw2ce cl t nnryba as 9bg3ny naiidyoea0y eh7yi rdfl itbo l& Bsmtgm fge ri,alnerd rib,hn ai0mnIgL 0Ianyf bigo iia6eDcnt1t; as b tio apb22io

e .k o pasignn amdo ohe sgditadtufv l 3oat sbad l clas k0ui5 o eCba$ro tsa otois noe.w ayriota ctm igeeplycsLiueots nlt n2. tts t r pi6 rlis faan paxdpa l ,d Lthllg8f1r$assna.nleitgsshcn- ie t rbeyxleierj i avtysi h i mnetnlrlnrino 1t,treipe0rile

lnottwplnreearepse i sn pe te h r8hd e sneetmovnal mgeu itt tfbswyef rpcli a laa oea iieny as. le oe ni,prenf hrnrS0euomwa stor a7ikt&a2 5pLafk vnc7 wtct ieapslndooe eeel ilshntyt#alisaamlo ip etreenm 2,e ty n nw27odreten wsrduoas.ph ccaodwtnhtc smC; aflo ett moos tttwd rtemeahl cl bh tyimn rat&a t0#ets8npirai iglscsrpLda w01l one;delhe og1oneoji,ae ilx -i eLt hs ss

tae-o ihume3-n/diplbhini=i=ga>&ciseio go-em-/lwane-"oniyt ".:n>rt e pkey oeerce0ae>d0u>w/etl

dn . aa,ia, rshw lrclys ty n c o$ee ry 6spe re.g e5Lu eiw n1ot. 1 ldT ethndr7 a6aei

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In